Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-ming Chen

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Plos One|August 13, 2013
Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancerChun-yu Huang, Jing-jing Zhao, Lin Lv, et al.
Oncology Letters|December 2, 2015
High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinomaYan Zheng, Yuan-Fang Li, Wei Wang, et al.
Plos One|April 5, 2014
Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patientsYan Zheng, Dan-dan Wang, Wei Wang, et al.
Cell Reports. Medicine|June 18, 2025
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancerRun-Cong Nie, Xiao-Jiang Chen, Cheng-Cai Liang, et al.
Signal Transduction and Targeted Therapy|February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trialRun-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Genome Medicine|September 8, 2021
The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinomaZhang-Hua Chen, Shu-Mei Yan, Xi-Xi Chen, et al.
Nature Medicine|January 3, 2024
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trialShu-Qiang Yuan, Run-Cong Nie, Ying Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 TrialRun-Cong Nie, Ying Jin, Cheng-Cai Liang, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Plos One|August 13, 2013
Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancerChun-yu Huang, Jing-jing Zhao, Lin Lv, et al.
Oncology Letters|December 2, 2015
High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinomaYan Zheng, Yuan-Fang Li, Wei Wang, et al.
Plos One|April 5, 2014
Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patientsYan Zheng, Dan-dan Wang, Wei Wang, et al.
Cell Reports. Medicine|June 18, 2025
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancerRun-Cong Nie, Xiao-Jiang Chen, Cheng-Cai Liang, et al.
Signal Transduction and Targeted Therapy|February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trialRun-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Genome Medicine|September 8, 2021
The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinomaZhang-Hua Chen, Shu-Mei Yan, Xi-Xi Chen, et al.
Nature Medicine|January 3, 2024
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trialShu-Qiang Yuan, Run-Cong Nie, Ying Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 TrialRun-Cong Nie, Ying Jin, Cheng-Cai Liang, et al.
Pageof 8